Thoroughly modern medicine

Molecular Genetics and Metabolism

Volumn 104, Issue 1-2, 2011, Pages 1-2

  Arnold, Georgianne L ^a   Vockley, Jerry ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; DATA BASE; EVIDENCE BASED MEDICINE; EXOME; FEASIBILITY STUDY; GENETIC DISORDER; GENETIC PROCEDURES; HUMAN; INBORN ERROR OF METABOLISM; MICROARRAY ANALYSIS; NANOTECHNOLOGY; NEWBORN SCREENING; NOTE; PERSONALIZED MEDICINE; PHARMACOGENETICS; PRIORITY JOURNAL; TUMOR CLASSIFICATION;

DELIVERY OF HEALTH CARE; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; MASS SCREENING; METABOLISM, INBORN ERRORS; STATISTICS AS TOPIC;

EID: 80052517758     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.07.011     Document Type: Note

References (13)

1. Langreth R., Waldholz M. New era of personalized medicine: targeting drugs for each unique genetic profile. Oncologist 1999, 4:426-427.
2. Flexner A. Medical Education in the United States and Canada: A Report to the Carnegie Foundation for the Advancement of Teaching 1910, Caregie Foundation for the Advancement of Teaching, New York.
3. McGhee S.A. How the practice of allergy shows the promise and challenge of personalized medicine. Mol Genet Metab 2011, 104:3-6. (this issue).
4. Wolf B. The neurology of biotinidase deficiency. Mol Genet Metab 2011, 104:27-34. (this issue).
5. Strauss K.A., Brumbaugh J., Duffy A., Wardley B., Robinson D., Hendrickson C., Tortorelli S., Moser A.B., Puffenberger E.G., Rider N.L., Morton H. Safety, efficacy and physiological actions of a new lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab 2011, 104:93-106. (this issue).
6. Solomon B.D., Pineda-Alvarez D.E., Hadley D.W., Teer J.K., Cherukuri P.F., Hansen N.F., Cruz P., Young A.C., Blakesley R.W., Lanpher B., Gibson S.M., Sincan M., Chandrasekharappa S.C., Mullikin J.C. Personalized genomic medicine: lessons from the exome. Mol Genet Metab 2011, 104:189-191. (this issue).
7. Saada A. The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases. Mol Genet Metab 2011, 104:39-47. (this issue).
8. Mazilu J.K., McCabe E.R.B. Moving toward personalized cell-based interventions for adrenal cortical disorders: part 1 - adrenal development and function, and roles of transcription factors and signaling proteins. Mol Genet Metab 2011, 104:72-79. (this issue).
9. Mazilu J.K., McCabe E.R.B. Moving toward personalized cell-based interventions for adrenal cortical disorders: part 2 - human diseases and tissue engineering. Mol Genet Metab 2011, 104:80-88. (this issue).
10. Ghai S.J., Sreentah Nagamani S.C., Blaser S., Siriwardena K., Feigenbaum A. Arginase I deficiency: severe infantile presentation with hypoammonemia: more common than reported?. Mol Genet Metab 2011, 104:107-111. (this issue).
11. Horowitz M., Pasmanik-Chor M., Ron I., Kolodny E.H. The enigma of the E326K mutation in acid beta-glucocerebrosidase. Mol Genet Metab 2011, 104:35-38. (this issue).
12. Oster-Granite M.L., Parisi M., Abbeduto L., Berlin D.S., Bodine C., Bynum D., Capone G., Collier E., Hall D., Kaeser L., Kaufmann P., Krischer J., Livingston M., McCabe L.L., Pace J., Pfenninger K., Rsamussen S.A., Reeves R.H., Rubinstein Y., Sherman S., Terry S.F., Sie Whitten M., Williams S., McCabe E.R.B., Maddox Y.T. Conference Proceedings: Down syndrome: National Conference on patient registries, research databases and biobanks. Mol Genet Metab 2011, 104:13-20. (this issue).
13. McCabe L.L., McCabe E.R.B. Down syndrome: issues to consider in a national registry, research database and biobank. Mol Genet Metab 2011, 104:10-12. (this issue).